相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
Daniel T. Harris et al.
JOURNAL OF IMMUNOLOGY (2018)
T-cell receptor-engineered T cells for cancer treatment: current status and future directions
Yu Ping et al.
PROTEIN & CELL (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies
Baixin Ye et al.
CANCER LETTERS (2018)
Engineering T cells for adoptive therapy: outsmarting the tumor
Andre Kunert et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Driving T-cell immunotherapy to solid tumors
Ken Garber
NATURE BIOTECHNOLOGY (2018)
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
Yiyang Xu et al.
CELL DISCOVERY (2018)
Chimeric antigen receptor T cells: a novel therapy for solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells
Zeming Mo et al.
JOURNAL OF CANCER (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
Marek Wieczorek et al.
FRONTIERS IN IMMUNOLOGY (2017)
Major Highlights of the CAR-TCR Summit, Boston, 2016
Vita Golubovskaya et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Kristin G. Anderson et al.
CANCER CELL (2017)
Optimizing T-cell receptor gene therapy for hematologic malignancies
Emma C. Morris et al.
BLOOD (2016)
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
Laurie Menger et al.
CANCER RESEARCH (2016)
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
Mark O'Hara et al.
IMMUNOTHERAPY (2016)
New Strategies for the Treatment of Solid Tumors with CAR-T Cells
Hao Zhang et al.
International Journal of Biological Sciences (2016)
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System
Drew C. Deniger et al.
MOLECULAR THERAPY (2016)
MEDICINE Paying for future success in gene therapy
Stuart H. Orkin et al.
SCIENCE (2016)
Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors
Daniel T. Harris et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Toxicities Associated With Adoptive T-Cell Transfer for Cancer
James C. Yang
CANCER JOURNAL (2015)
T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells
M. P. Tan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Translational Implications of Tumor Heterogeneity
Mariam Jamal-Hanjani et al.
CLINICAL CANCER RESEARCH (2015)
Cardiac endothelial cells express Wilms' tumor-1 Wt1 expression in the developing, adult and infarcted heart
Sjoerd N. Duim et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor
Joost H. van den Berg et al.
MOLECULAR THERAPY (2015)
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
Matthias Obenaus et al.
NATURE BIOTECHNOLOGY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control
Jennifer D. Stone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
CAR T Cells for Solid Tumors Armed and Ready to Go?
Sunitha Kakarla et al.
CANCER JOURNAL (2014)
Intratumoral Immunization: A New Paradigm for Cancer Therapy
Aurelien Marabelle et al.
CLINICAL CANCER RESEARCH (2014)
Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor
Ann M. Leen et al.
MOLECULAR THERAPY (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection
Thomas M. Schmitt et al.
BLOOD (2013)
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1-and LAGE-1-positive tumors
Emmet McCormack et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Interleukin 15 Provides Relief to CTLs from Regulatory T Cell-Mediated Inhibition: Implications for Adoptive T Cell-Based Therapies for Lymphoma
Serena K. Perna et al.
CLINICAL CANCER RESEARCH (2013)
Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry
Anna Marie Mulligan et al.
CLINICAL CANCER RESEARCH (2013)
Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas
Sid P. Kerkar et al.
MOLECULAR THERAPY (2013)
Persistence and Efficacy of Second Generation CAR T Cell Against the LeY Antigen in Acute Myeloid Leukemia
David S. Ritchie et al.
MOLECULAR THERAPY (2013)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Cor H. J. Lamers et al.
MOLECULAR THERAPY (2013)
Presentation of Phagocytosed Antigens by MHC Class I and II
Adriana R. Mantegazza et al.
TRAFFIC (2013)
TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitenss, and sensitization of tumor milieu
Andre Kunert et al.
FRONTIERS IN IMMUNOLOGY (2013)
Adoptive Transfer of Cytotoxic T Lymphocytes Targeting Two Different Antigens Limits Antigen Loss and Tumor Escape
Karen M. Kaluza et al.
HUMAN GENE THERAPY (2012)
The role of the myofibroblast in tumor stroma remodeling
Marcela Otranto et al.
CELL ADHESION & MIGRATION (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The role of the PD-1 pathway in autoimmunity and peripheral tolerance
Brian T. Fife et al.
YEAR IN IMMUNOLOGY (2011)
An active murine-human chimeric Fab antibody derived from Escherichia coli, potential therapy against over-expressing VEGFR2 solid tumors
Jianfei Huang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Translating Tumor Antigens into Cancer Vaccines
Luigi Buonaguro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms
Oleg Y. Borbulevych et al.
JOURNAL OF IMMUNOLOGY (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines
Siina Junnila et al.
BMC CANCER (2010)
Mesothelial proteins are expressed in the human cornea
Katerina Jirsova et al.
EXPERIMENTAL EYE RESEARCH (2010)
WT1 (Wilms' Tumor Gene 1): Biology and Cancer Immunotherapy
Haruo Sugiyama
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Automated Network Analysis Identifies Core Pathways in Glioblastoma
Ethan Cerami et al.
PLOS ONE (2010)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
MHC class II transport at a glance
Adam C. Berger et al.
JOURNAL OF CELL SCIENCE (2009)
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
Ina Radtke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma
Julie R. Park et al.
MOLECULAR THERAPY (2007)
PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells
Y Iwai et al.
INTERNATIONAL IMMUNOLOGY (2005)
The MHC class I antigen presentation pathway: strategies for viral immune evasion
EW Hewitt
IMMUNOLOGY (2003)
Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
MH Kershaw et al.
HUMAN GENE THERAPY (2002)
Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3εγ heterodimer
ZYJ Sun et al.
CELL (2001)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
分享论文
